{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:14:24Z","timestamp":1761822864659},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf02306286","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T02:26:42Z","timestamp":1139970402000},"page":"295-303","source":"Crossref","is-referenced-by-count":32,"title":["Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique"],"prefix":"10.1007","volume":"3","author":[{"given":"Harold J.","family":"Wanebo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen A.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey I.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Vezeridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Belliveau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02306286_CR1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","volume":"148","author":"O Creech","year":"1959","unstructured":"Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer; regional perfusion utilizing an extracorporeal circuit.Ann Surg 1959;148:616\u201332.","journal-title":"Ann Surg"},{"key":"BF02306286_CR2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM195911192612101","volume":"261","author":"WA Austen","year":"1959","unstructured":"Austen WA, Monaco AP, Richardson GS, et al. Treatments of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents.N Engl J Med 1959;261:1037.","journal-title":"N Engl J Med"},{"key":"BF02306286_CR3","first-page":"464","volume":"111","author":"E Watkins Jr","year":"1960","unstructured":"Watkins E Jr, Hering AC, Luna R, Adams HD. The use of intravascular balloon catheters for isolation of the pelvic bed during pump oxygenator perfusion of cancer chemotherapeutic agents.Surg Gynecol Obstet 1960;111:464\u20138.","journal-title":"Surg Gynecol Obstet"},{"key":"BF02306286_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00000658-196004000-00024","volume":"151","author":"JS Stehlin","year":"1960","unstructured":"Stehlin JS, Clark RL, White EC. Regional chemotherapy for cancer: experience with 116 perfusions.Ann Surg 1960;151:605.","journal-title":"Ann Surg"},{"key":"BF02306286_CR5","first-page":"260","volume":"50","author":"WW Shingleton","year":"1961","unstructured":"Shingleton WW, Parker RT, Mahaley S. Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia.Surgery 1961;50:260\u20135.","journal-title":"Surgery"},{"key":"BF02306286_CR6","first-page":"248","volume":"50","author":"W Lawrence Jr","year":"1961","unstructured":"Lawrence W Jr, Kuehn P, Mori S. Regional perfusion of the pelvis: considerations of the leakage problem.Surgery 1961;50:248\u201359.","journal-title":"Surgery"},{"key":"BF02306286_CR7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/1097-0142(196305)16:5<567::AID-CNCR2820160505>3.0.CO;2-H","volume":"16","author":"W Lawrence Jr","year":"1963","unstructured":"Lawrence W Jr, Clarkson B, Kim M, Clapp P, Randall HT. Regional perfusion of pelvis and abdomen by an indirect technique.Cancer 1963;16:567.","journal-title":"Cancer"},{"key":"BF02306286_CR8","first-page":"47","volume":"17","author":"JC Lathrop","year":"1963","unstructured":"Lathrop JC, Leone LA, Soderberg CH, Colbert MP, Vargas LL. Perfusion chemotherapy for gynecological malignancy.Trans N Engl Obstet Gynecol Soc 1963;17:47\u201356.","journal-title":"Trans N Engl Obstet Gynecol Soc"},{"key":"BF02306286_CR9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archsurg.1962.01310030078013","volume":"85","author":"DG Miller","year":"1962","unstructured":"Miller DG, Lawrence W. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.Arch Surg 1962;85:430\u201341.","journal-title":"Arch Surg"},{"key":"BF02306286_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archsurg.1987.01400230107019","volume":"122","author":"A Wile","year":"1987","unstructured":"Wile A, Smolin M. Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer.Arch Surg 1987;122:1321\u20135.","journal-title":"Arch Surg"},{"key":"BF02306286_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archsurg.1993.01420170067009","volume":"128","author":"PS Turk","year":"1993","unstructured":"Turk PS, Belliveau JF, Darnowski JW, et al. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.Arch Surg 1993;128:533\u20139.","journal-title":"Arch Surg"},{"key":"BF02306286_CR12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-9610(79)90088-6","volume":"137","author":"L Hafstrom","year":"1979","unstructured":"Hafstrom L, Jonsson PE, Landberg T, et al. Intra-arterial infusion chemotherapy (5-FU) in patients with inextirpable or locally recurrent rectal cancer.Am J Surg 1979;137:757\u201362.","journal-title":"Am J Surg"},{"key":"BF02306286_CR13","first-page":"15","volume-title":"Recent results in cancer research","author":"RA Oberfield","year":"1983","unstructured":"Oberfield RA. Intra-arterial infusion in tumors of the pelvis. In:Recent results in cancer research. Berlin: Springer-Verlag, 1983:15\u201325."},{"key":"BF02306286_CR14","first-page":"37","volume-title":"Recent results in cancer research","author":"ME Heim","year":"1983","unstructured":"Heim ME, Eberwein S, Georgi M. Palliative therapy of pelvis tumors by intra-arterial infusion of cytotoxic drugs. In:Recent results in cancer research. Berlin: Springer-Verlag, 1983:37\u201340."},{"key":"BF02306286_CR15","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/1097-0142(19851101)56:9<2175::AID-CNCR2820560906>3.0.CO;2-3","volume":"56","author":"Y Patt","year":"1985","unstructured":"Patt Y, Peters RE, Chuang VP, et al. Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-FU and mitomycin.Cancer 1985;56:2175\u201380.","journal-title":"Cancer"},{"key":"BF02306286_CR16","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/1097-0142(19860515)57:10<1952::AID-CNCR2820571011>3.0.CO;2-S","volume":"57","author":"KC Wright","year":"1986","unstructured":"Wright KC, Wallace S, Kim EE, et al. Pulsed arterial perfusions: chemotherapeutic implications.Cancer 1986;57:1952\u20136.","journal-title":"Cancer"},{"key":"BF02306286_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1097-0142(19860715)58:2<336::AID-CNCR2820580222>3.0.CO;2-F","volume":"58","author":"C Carlsson","year":"1986","unstructured":"Carlsson C, Hafstrom L, Jonsson PE, Ask A, Kallum B, Lunderquist A. Unresectable and locally recurrent rectal cancer treated with radiotherapy or bilateral internal iliac artery infusion of 5-FU.Cancer 1986;58:336\u201340.","journal-title":"Cancer"},{"key":"BF02306286_CR18","first-page":"84","volume":"80","author":"RL Dedrich","year":"1986","unstructured":"Dedrich RL. Arterial drug infusion: pharmacokinetic implications: problems and pitfalls.Cancer 1986;JNCI 80:84\u20139.","journal-title":"Cancer"},{"key":"BF02306286_CR19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archsurg.1991.01410350080012","volume":"126","author":"JH Muchmore","year":"1991","unstructured":"Muchmore JH, Kramentz ET, Carter RD, Preslan JE, George WI. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration.Arch Surg 1991;126:1390\u20136.","journal-title":"Arch Surg"},{"key":"BF02306286_CR20","first-page":"3869","volume":"48","author":"AA Forastiere","year":"1988","unstructured":"Forastiere AA, Belliveau JF, Goren M, Vogel WC, Posner MC, O'Leary GP. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cisdiaminedichloroplatinum (II) in head and neck cancer patients.Cancer Res 1988;48:3869\u201374.","journal-title":"Cancer Res"},{"key":"BF02306286_CR21","first-page":"1310","volume":"33","author":"RC DeConti","year":"1973","unstructured":"DeConti RC, Toftness BR, Lange RC, Cresey WA. Clinical and pharmacological studies with cis-diaminedichloroplatinum.Cancer Res 1973;33:1310\u201315.","journal-title":"Cancer Res"},{"key":"BF02306286_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00552728","volume":"14","author":"JW Darnowski","year":"1985","unstructured":"Darnowski JW, Sawyer RC, Stolfi RL, Martin DS, Lau-Cam CA. Decreased toxicity in vivo during chronic treatment for 5-fluorouracil.Cancer Chemother Pharmacol 1985;14:63\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02306286_CR23","first-page":"3479","volume":"38","author":"WE MacMillan","year":"1978","unstructured":"MacMillan WE, Wolberg WH, Welling PG. Pharmacokinetics of fluorouracil in humans.Cancer Res 1978;38:3479\u201382.","journal-title":"Cancer Res"},{"key":"BF02306286_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0003-2670(01)83960-X","volume":"127","author":"J Hartigh den","year":"1981","unstructured":"den Hartigh J, van Oort WJ. High-performance liquid chromatographic determination of the antitumor agent mitomycin C in human blood plasma.Anal Chim Acta 1981;127:47\u201353.","journal-title":"Anal Chim Acta"},{"key":"BF02306286_CR25","first-page":"775","volume":"48","author":"AC Sartorelli","year":"1988","unstructured":"Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: presidential address.Cancer Res 1988;48:775\u20138.","journal-title":"Cancer Res"},{"key":"BF02306286_CR26","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#","volume":"20","author":"R Cavaliere","year":"1967","unstructured":"Cavaliere R, Ciocatto BC, Giovanelli BC, et al. Selective heat sensitivity of cancer cells.Cancer 1967;20:1351\u201381","journal-title":"Cancer"},{"key":"BF02306286_CR27","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/0006-2952(92)90142-6","volume":"43","author":"LD Nord","year":"1992","unstructured":"Nord LD, Stolfi RL, Martin DS. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue: correlation of antitumor activity with dosage and FUra incorporation into RNA.Biochem Pharmacol 1992;43:2543\u20139.","journal-title":"Biochem Pharmacol"},{"key":"BF02306286_CR28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.1995.13.1.264","volume":"13","author":"AK Thom","year":"1995","unstructured":"Thom AK, Alexander HR, Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and syustemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.J Clin Oncol 1995;13:264\u201373.","journal-title":"J Clin Oncol"},{"key":"BF02306286_CR29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0959-8049(05)80163-7","volume":"294","author":"FJ Lejeune","year":"1993","unstructured":"Lejeune FJ, Lienard D, Leyvraz S, et al. Regional chemotherapy of melanoma.Eur J Cancer 1993;294:606\u201312.","journal-title":"Eur J Cancer"},{"key":"BF02306286_CR30","first-page":"301","volume":"4","author":"HJ Hoekstra","year":"1992","unstructured":"Hoekstra HJ, Naujocks T, Koops HS, et al. Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results.Reg Cancer Treat 1992;4:301\u20134.","journal-title":"Reg Cancer Treat"},{"key":"BF02306286_CR31","first-page":"146","volume":"10","author":"L Keenan","year":"1991","unstructured":"Keenan L, Turk PS, Vezeridis MP, Wanebo HJ. Isolated pelvic perfusion in a canine model: patient treatment considerations.Proc Am Soc Clin Oncol 1991;10:146.","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02306286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02306286\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02306286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T20:21:30Z","timestamp":1557951690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02306286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF02306286"],"URL":"https:\/\/doi.org\/10.1007\/bf02306286","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}